Guillain-Barré syndrome associated with COVID-19 disease
Sindhuja Korem, Haresh Gandhi, Decerie B. Dayag
Abstract
Clinical manifestations of COVID-19 are known to be variable with growing evidence of nervous system involvement. In this case report, we describe the symptoms of a patient infected with SARS-CoV-2 whose clinical course was complicated with Guillain-Barré syndrome (GBS). We present a case of a 58-year-old woman who was initially diagnosed with COVID-19 pneumonia due to symptoms of fever and cough. Two weeks later, after the resolution of upper respiratory tract symptoms, she developed symmetric ascending quadriparesis and paresthesias. The diagnosis of GBS was made through cerebrospinal fluid analysis and she was successfully treated with intravenous immunoglobulin administration.
Topics & Concepts
MedicineGuillain-Barre syndromeCoronavirus disease 2019 (COVID-19)Upper respiratory tract infectionPneumoniaPediatricsCerebrospinal fluidIntravenous Immunoglobulin TherapyIntravenous ImmunoglobulinsDiseaseAntibodyInternal medicineImmunologyInfectious disease (medical specialty)Long-Term Effects of COVID-19Peripheral Neuropathies and DisordersInfectious Encephalopathies and Encephalitis